– Veteran executive with over 20 years of oncology leadership and clinical experience with proven track record of success in bringing development candidates through late-stage clinical development – – Company will hold a conference call on July 29 at 4:30 p.m. ET/1:30 p.m. PT to share additional clinical data from its randomized Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer (“mCRC”) – SAN DIEGO, June 17, 2025 (GLOBE ...

CONSHOHOCKEN, Pa., June 17, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on June 15, 2025 to 36 new non-executive employees as equity inducement awards under the terms of Madrigal’s 2023 Inducement Plan. The equity awards were approved by Madrigal’s independent Compensation Committee in accordance with Nasdaq ...

Evan Bailey, MD, promoted to Chief Medical Officer, succeeding Riccardo Perfetti, MD, PhDDottie Caplan promoted to Executive Vice President, Patient Advocacy and Government Affairs NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced key appointments to its executive leadership team with the promotions of Evan Bailey, MD, to Chief Medical Officer (CMO), effective Ju ...

Company to be Renamed “BCP Investment Corporation” and Trade Under New Ticker “BCIC” Transition to Paying the Quarterly Base Distribution Monthly in 2026 Company, Management, Adviser and Other Affiliates Intend to Acquire up to 20% of Common Shares Over Next 24 Months to the Extent the Stock Trades Below 80% of NAV NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (NASDAQ: PTMN) (“Portman Ridge” or “PTMN”), today announced several updates and initiatives, aimed at enhancing shar ...

Joby Aviation TodayJOBYJoby Aviation$8.66 -0.34 (-3.78%) 52-Week Range$4.66▼$10.72Price Target$9.33Add to WatchlistRecent trading in Joby Aviation NYSE: JOBY shares highlights a sharp divide between short-term market noise and the company’s long-term progress. The stock took a noticeable dip after one of Joby’s market analysts issued a downgrade, creating a wave of caution through the retail investment community. This view, however, clashes with a powerful string of fundamental wins for the company. A rece ...

CHICAGO, June 17, 2025 /PRNewswire/ -- CME Group Inc. will announce earnings for the second quarter of 2025 before the markets open on Wednesday, July 23, 2025. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions.A live audio Webcast of the conference ca ...

Revenues increased 220% to $3.7 million, compared with $1.2 million for the fiscal year ended March 31, 2024 Expect to report revenue of at least $1.7 million for quarter ending June 30, 2025, and introducing revenue guidance of $12-$16 million for the full fiscal year 2026 Submitted PMA supplement for second-generation LungFit® PH to FDA International distribution partnerships now provide access to markets representing over 2 billion lives, with LungFit® PH actively shipping to Europe, Australia, and the ...

Key Takeaways CVS stock has jumped 53.7% in 2025 on strong operations and a friendlier regulatory landscape. Removal of PBM and Medicare Advantage cuts boosts CVS' Caremark and Aetna business lines. CVS' digital care push, cost savings and expanded access are reinforcing its 2025 growth trajectory.CVS Health (CVS) has seen its stock surge by 53.7% in 2025, fueled by a potent combination of strong operational performance and a favorable regulatory outlook. The company raised its full-year 2025 EPS guidance ...

Key Takeaways Intuit, Dave and Centrus Energy were selected for strong profitability based on net income ratio. LEU leads with a 22.6% net profit margin, followed by INTU at 19.1% and DAVE at 13.8%. All three picks also show above-industry sales and net income growth over the past 12 months.Investors should prioritize profitable companies over loss-making ones to ensure solid returns after covering all costs. We have used accounting ratios to evaluate a company’s profitability. There are several profitabi ...

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against 3D Systems Corporation (“3D Systems” or “the Company”) (NYSE: DDD) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired 3D Sy ...